Mirae Asset Global Etfs Holdings Ltd. Iovance Biotherapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 145,760 shares of IOVA stock, worth $1.48 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
145,760Holding current value
$1.48 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IOVA
# of Institutions
323Shares Held
239MCall Options Held
1.27MPut Options Held
1.68M-
Vanguard Group Inc Valley Forge, PA26MShares$264 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY25.9MShares$264 Million6.02% of portfolio
-
Mhr Fund Management LLC New York, NY24MShares$244 Million28.39% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$216 Million0.0% of portfolio
-
State Street Corp Boston, MA12.6MShares$128 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $1.6B
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...